Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1

By Ars Elisabet   Serra Eduard   García Judit   Kruyer Helena   Gaona Antonia   Lázaro Conxi   Estivill Xavier  

Human Molecular Genetics, Vol. 9, Iss. 2, 2000-01 ,pp. : 237-247

Oxford University Press

Access to resources Recommend Favorite

Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras

By Hannan Frances   Ho Ivan   Zhu Yinghua   Nurnberg Peter   Zhong Yi  

Human Molecular Genetics, Vol. 15, Iss. 7, 2006-04 ,pp. : 1087-1098

Oxford University Press

Access to resources Recommend Favorite

Two Novel COH1 Mutations in an Italian Patient with Cohen Syndrome

By  

Molecular Syndromology, Vol. 3, Iss. 1, 2012-05 ,pp. : 30-33

Karger

Access to resources Recommend Favorite

NF2 gene in neurofibromatosis type 2 patients

By Giraud S.  

Human Molecular Genetics, Vol. 7, Iss. 13, 1998-12 ,pp. : 2095-2101

Oxford University Press

Access to resources Recommend Favorite

Genetic and clinical mosaicism in a patient with neurofibromatosis type 1

By Vandenbroucke Ina   Doorn Remco   Callens Tom   Cobben Jan   Starink Theo   Messiaen Ludwine  

Human Genetics, Vol. 114, Iss. 3, 2004-02 ,pp. : 284-290

Springer Publishing Company

Access to resources Recommend Favorite